🇺🇸 FDA
Patent

US 11801265

Preparation method of NK cells and use thereof in the treatment of cancer

granted A61KA61K2039/505A61K2239/31

Quick answer

US patent 11801265 (Preparation method of NK cells and use thereof in the treatment of cancer) held by SINO UNITED (BEIJING) BIOMEDICAL TECHNOLOGY CO., LTD. expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SINO UNITED (BEIJING) BIOMEDICAL TECHNOLOGY CO., LTD.
Grant date
Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/505, A61K2239/31, A61K2239/38, A61K2239/50